Literature DB >> 15159023

DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.

Chelsee Hewitt1, Peter Wilson, Edwina McGlinn, Gary MacFarlane, Anne Papageorgiou, Robert T M Woodwards, Philip Sloan, Susanne M Gollin, Ian Paterson, Kenneth K Parkinson, Andrew P Read, Nalin Thakker.   

Abstract

Allelic imbalance on chromosome arm 8p is common in head and neck squamous cell carcinoma (HNSCC). DLC1, a tumour suppressor gene inactivated in liver carcinogenesis and encoding a Rho GTPase activating protein (RhoGAP) maps to one of the deleted regions (8p21.3-22). In order to determine whether inactivation of DLC1 is involved in HNSCC, we have screened tumour cell lines for DLC1 mutations and expression. Pathological mutations were not identified in any of the 17 cell lines tested. Seven polymorphisms were identified; 13 of the 17 of cell lines were homozygous for all seven polymorphisms compared to only 2 of 17 controls suggesting a loss of heterozygosity in a majority of the cell lines. DLC1 expression was observed in all 11 HNSCC cell lines tested, thus excluding the possibility of transcriptional silencing of DLC1 by promoter hypermethylation. Overall, our data suggest that hemizygous deletions of the DLC1 locus are frequent in HNSCCs but this gene is unlikely to be primary target for inactivation on this chromosomal arm. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159023     DOI: 10.1016/j.canlet.2003.12.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

2.  Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.

Authors:  Yi-Chun Liao; Yi-Ping Shih; Su Hao Lo
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

3.  High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.

Authors:  Y-F Song; R Xu; X-H Zhang; B-B Chen; Q Chen; Y-M Chen; Y Xie
Journal:  J Clin Pathol       Date:  2006-02-17       Impact factor: 3.411

Review 4.  DLC-1:a Rho GTPase-activating protein and tumour suppressor.

Authors:  Marian E Durkin; Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Douglas R Lowy; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.